Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1914-02-9

Post Buying Request

1914-02-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1914-02-9 Usage

General Description

3,3-Dimethyl-2,3-dihydro-1H-indole is a chemical compound belonging to the group of indoles, which are heterocyclic aromatic organic compounds. This particular compound contains additional methyl groups, making it a derivative of indole. Its chemical formula is C11H13N. Due to its complex structure, this indole compound is likely to have distinct properties and potentially find applications in diverse fields such as pharmaceuticals, dyes, or agrochemicals. Its physical characteristics and specific uses would be determined by the way the indole and methyl groups react with other substances.

Check Digit Verification of cas no

The CAS Registry Mumber 1914-02-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,9,1 and 4 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1914-02:
(6*1)+(5*9)+(4*1)+(3*4)+(2*0)+(1*2)=69
69 % 10 = 9
So 1914-02-9 is a valid CAS Registry Number.

1914-02-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 3,3-dimethyl-1,2-dihydroindole

1.2 Other means of identification

Product number -
Other names 3,3-methylindoline

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1914-02-9 SDS

1914-02-9Synthetic route

3,3-dimethyloxindole
19155-24-9

3,3-dimethyloxindole

3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

Conditions
ConditionsYield
With sodium bis(2-methoxyethoxy)aluminium dihydride In toluene at 75℃; for 0.75h;95%
Stage #1: 3,3-dimethyloxindole With lithium aluminium tetrahydride In tetrahydrofuran at 0℃; for 4h; Heating / reflux;
Stage #2: With water In tetrahydrofuran
89%
Stage #1: 3,3-dimethyloxindole With lithium aluminium tetrahydride In tetrahydrofuran at 60℃; for 1h; Inert atmosphere;
Stage #2: With water In tetrahydrofuran at 0℃;
88%
1-(3,3-dimethylindolin-1-yl)ethan-1-one
16078-32-3

1-(3,3-dimethylindolin-1-yl)ethan-1-one

3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

Conditions
ConditionsYield
Stage #1: 1-(3,3-dimethylindolin-1-yl)ethan-1-one With hydrogenchloride In methanol at 50℃; for 16h;
Stage #2: With water pH=8;
94%
With hydrogenchloride Heating; Yield given;
3,3-dimethylindolenine
1504-14-9

3,3-dimethylindolenine

3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

Conditions
ConditionsYield
With sodium tetrahydroborate; water; sodium hydroxide In n-heptane at 10℃; for 3h; pH=~ 13;85%
With copper oxide-chromium oxide at 150 - 170℃; under 25742.8 Torr; Hydrogenation;
1-azido-2-tert-butylbenzene
20442-98-2

1-azido-2-tert-butylbenzene

3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

Conditions
ConditionsYield
With bis{rhodium[3,3'-(1,3-phenylene)bis(2,2-dimethylpropanoic acid)]} In toluene at 120℃; for 16h; Inert atmosphere;75%
With tetrabutylammonium tricarbonylnitrosylferrate In 1,2-dichloro-ethane; N,N-dimethyl-formamide at 120℃; for 1h; Catalytic behavior; Solvent; Temperature; Reagent/catalyst; Microwave irradiation; Inert atmosphere;
2-bromo-β,β-dimethylbenzeneethanamine
71095-49-3

2-bromo-β,β-dimethylbenzeneethanamine

potassium selenocyanate
3425-46-5

potassium selenocyanate

A

3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

B

3,4-dihydro-4,4-dimethyl-2H-1,2-benzoselenazine

3,4-dihydro-4,4-dimethyl-2H-1,2-benzoselenazine

Conditions
ConditionsYield
With copper(l) iodide; triethylamine In N,N-dimethyl-formamide at 20℃; for 24h;A n/a
B 68%
2-iodo-N-(2-methylallyl)aniline
73396-94-8

2-iodo-N-(2-methylallyl)aniline

3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

Conditions
ConditionsYield
With tetrabutyl-ammonium chloride; sodium formate; triethylamine; palladium diacetate In N,N-dimethyl-formamide at 80℃; for 24h;65%
(2-Bromo-phenyl)-(2-methyl-allyl)-amine
207122-91-6

(2-Bromo-phenyl)-(2-methyl-allyl)-amine

3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

Conditions
ConditionsYield
With palladium diacetate; sodium hydrogencarbonate In N,N-dimethyl-formamide at 90℃;65%
3,3-dimethyl-2,3-dihydroindol-2-thione
19155-25-0

3,3-dimethyl-2,3-dihydroindol-2-thione

3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

Conditions
ConditionsYield
With nickel In methanol for 1h; Heating;60%
1-Benzyl-3,3-dimethylindoline-2-thione
116916-38-2

1-Benzyl-3,3-dimethylindoline-2-thione

A

3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

B

1-Benzyl-3,3-dimethylindoline
19501-85-0

1-Benzyl-3,3-dimethylindoline

Conditions
ConditionsYield
With nickel In tetrahydrofuran; toluene for 1h; Heating;A 60%
B 6%
With nickel In methanol for 1h; Heating;A 60%
B 6%
isobutyraldehyde
78-84-2

isobutyraldehyde

phenylhydrazine
100-63-0

phenylhydrazine

3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

Conditions
ConditionsYield
In acetic acid at 80℃;50%
2-methyl-2-(2-nitrophenyl)proponic acid ethyl ester

2-methyl-2-(2-nitrophenyl)proponic acid ethyl ester

A

3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

B

2-<(1-Hydroxy-2-methyl)-2-propyl>-aniline

2-<(1-Hydroxy-2-methyl)-2-propyl>-aniline

Conditions
ConditionsYield
With lithium borohydride In toluene 1.) 100 deg C, 4 h, 2.) r.t., overnight;A 15%
B 28%
C20H22BF3N6Ni

C20H22BF3N6Ni

3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

Conditions
ConditionsYield
With tetrabutylammoniun azide In acetonitrile at 20℃; for 15h; Inert atmosphere;20%
2,3-dihydro-1,3,3-trimethylindole
105278-05-5

2,3-dihydro-1,3,3-trimethylindole

3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

Conditions
ConditionsYield
With ammonium iodide; hydrogen iodide at 215 - 230℃;
(+-)-6,6,12,12,18,18-hexamethyl-(5ar,11ac,17at)-5a,6,11a,12,17a,18-hexahydro-<1,3,5>triazino<1,2-a;3,4-a';5,6-a''>triindole

(+-)-6,6,12,12,18,18-hexamethyl-(5ar,11ac,17at)-5a,6,11a,12,17a,18-hexahydro-<1,3,5>triazino<1,2-a;3,4-a';5,6-a''>triindole

3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

Conditions
ConditionsYield
With copper oxide-chromium oxide at 150 - 170℃; under 25742.8 Torr; Hydrogenation;
1,4-dioxane
123-91-1

1,4-dioxane

3,3-dimethyloxindole
19155-24-9

3,3-dimethyloxindole

diethyl ether
60-29-7

diethyl ether

lithium alanate

lithium alanate

3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

Conditions
ConditionsYield
unter Stickstoff;
3,3-dimethyloxindole
19155-24-9

3,3-dimethyloxindole

pentan-1-ol
71-41-0

pentan-1-ol

sodium

sodium

3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

trimer(ic) 3.3-dimethyl-indolenine

trimer(ic) 3.3-dimethyl-indolenine

3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

Conditions
ConditionsYield
With pentan-1-ol; sodium
2-bromoaniline
615-36-1

2-bromoaniline

3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 85 percent / K2CO3 / dimethylformamide / Ambient temperature
2: 65 percent / Pd(OAc)2, NaHCO3 / dimethylformamide / 90 °C
View Scheme
Acetanilid
103-84-4

Acetanilid

N-phenyl-N'-acetyl-urea

N-phenyl-N'-acetyl-urea

3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 99 percent / NaOH, tetrabutylammonium bromide / toluene / 2.25 h / 75 °C
2: AlCl3 / chlorobenzene / 110 - 115 °C
3: 6N HCl / Heating
View Scheme
N-(2-methylprop-2-ene-1-yl)-N-phenylacetamide
102860-03-7

N-(2-methylprop-2-ene-1-yl)-N-phenylacetamide

3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: AlCl3 / chlorobenzene / 110 - 115 °C
2: 6N HCl / Heating
View Scheme
Multi-step reaction with 2 steps
1.1: aluminum (III) chloride / chlorobenzene / 115 - 120 °C / Inert atmosphere
2.1: hydrogenchloride / methanol / 16 h / 50 °C
2.2: pH 8
View Scheme
1-Benzyl-3,3-dimethylindoline
19501-85-0

1-Benzyl-3,3-dimethylindoline

3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

Conditions
ConditionsYield
With carbonochloridic acid 1-chloro-ethyl ester; sodium iodide In acetone
1-acetyl-3,3-dimethylindolin-2-one
72934-84-0

1-acetyl-3,3-dimethylindolin-2-one

3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: hydrogenchloride / water / 1 h / Reflux
2.1: lithium aluminium tetrahydride / tetrahydrofuran / 1 h / 60 °C / Inert atmosphere
2.2: 0 °C
View Scheme
1-azido-2-tert-butyl-4-methoxybenzene
1373751-83-7

1-azido-2-tert-butyl-4-methoxybenzene

1-azido-2-tert-butylbenzene
20442-98-2

1-azido-2-tert-butylbenzene

A

3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

B

3,3-dimethyl-5-methoxy-indoline
87234-77-3

3,3-dimethyl-5-methoxy-indoline

Conditions
ConditionsYield
With bis{rhodium[3,3'-(1,3-phenylene)bis(2,2-dimethylpropanoic acid)]} In toluene at 120℃; for 3h; Inert atmosphere;
2-(1,1-dimethylethyl)-benzenamine
6310-21-0

2-(1,1-dimethylethyl)-benzenamine

3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 2-Methyl-2-nitropropane; trimethylsilylazide / acetonitrile / 20 °C / Inert atmosphere
2: bis{rhodium[3,3'-(1,3-phenylene)bis(2,2-dimethylpropanoic acid)]} / toluene / 16 h / 120 °C / Inert atmosphere
View Scheme
Multi-step reaction with 2 steps
1: 2-Methyl-2-nitropropane; trimethylsilylazide / acetonitrile / 20 °C / Inert atmosphere
2: bis{rhodium[3,3'-(1,3-phenylene)bis(2,2-dimethylpropanoic acid)]} / toluene / 3 h / 120 °C / Inert atmosphere
View Scheme
Multi-step reaction with 2 steps
1: tert.-butylnitrite; trimethylsilylazide / acetonitrile / 1 h / 0 - 20 °C
2: tetrabutylammonium tricarbonylnitrosylferrate / N,N-dimethyl-formamide; 1,2-dichloro-ethane / 1 h / 120 °C / Microwave irradiation; Inert atmosphere
View Scheme
Acetanilid
103-84-4

Acetanilid

3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: potassium carbonate; sodium hydroxide; tetrabutylammomium bromide / toluene / 75 °C
2.1: aluminum (III) chloride / chlorobenzene / 115 - 120 °C / Inert atmosphere
3.1: hydrogenchloride / methanol / 16 h / 50 °C
3.2: pH 8
View Scheme
N-acetyloxindole
21905-78-2

N-acetyloxindole

3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: lithium hexamethyldisilazane / Inert atmosphere
2: lithium aluminium tetrahydride / tetrahydrofuran / Inert atmosphere
View Scheme
2-methyl-2-phenylpropionitrile
1195-98-8

2-methyl-2-phenylpropionitrile

3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: dmap; triethylamine / dichloromethane / 24 h / 20 °C / Inert atmosphere
2: copper diacetate / N,N-dimethyl-formamide / 170 °C / Inert atmosphere; Schlenk technique
3: sodium hydroxide / ethanol; water / 4 h / 100 °C / Inert atmosphere
View Scheme
N-(2-methyl-2-phenylpropyl)picolinamide

N-(2-methyl-2-phenylpropyl)picolinamide

3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: copper diacetate / N,N-dimethyl-formamide / 170 °C / Inert atmosphere; Schlenk technique
2: sodium hydroxide / ethanol; water / 4 h / 100 °C / Inert atmosphere
View Scheme
(3,3-dimethylindolin-1-yl)(pyridin-2-yl)methanone
1352819-13-6

(3,3-dimethylindolin-1-yl)(pyridin-2-yl)methanone

3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

Conditions
ConditionsYield
With sodium hydroxide In ethanol; water at 100℃; for 4h; Inert atmosphere;24 mg
3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

acetyl chloride
75-36-5

acetyl chloride

1-(3,3-dimethylindolin-1-yl)ethan-1-one
16078-32-3

1-(3,3-dimethylindolin-1-yl)ethan-1-one

Conditions
ConditionsYield
With sodium hydrogencarbonate In dichloromethane at 0 - 20℃;97.1%
With sodium hydrogencarbonate In dichloromethane at 0℃; for 2h;97.1%
3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

ortho-nitrofluorobenzene
1493-27-2

ortho-nitrofluorobenzene

3,3-dimethyl-1-(2-nitrophenyl)indoline
917898-58-9

3,3-dimethyl-1-(2-nitrophenyl)indoline

Conditions
ConditionsYield
at 175℃; for 8h;95%
In neat (no solvent) at 175℃; Inert atmosphere; Microwave irradiation;
1-Methyl-4-piperidone
1445-73-4

1-Methyl-4-piperidone

3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

3,3-dimethyl-1-(1-methyl-4-piperidinyl)-2,3-dihydro-1H-indole
882669-59-2

3,3-dimethyl-1-(1-methyl-4-piperidinyl)-2,3-dihydro-1H-indole

Conditions
ConditionsYield
Stage #1: 1-Methyl-4-piperidone; 3,3-dimethylindoline In acetic acid for 0.0833333h;
Stage #2: With sodium tris(acetoxy)borohydride In acetic acid for 0.5h;
94%
3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

3-phenyl-(2R,3R)-oxiran-2-ylmethanol
98819-68-2

3-phenyl-(2R,3R)-oxiran-2-ylmethanol

(2S,3S)-3-(3,3-dimethyl-2,3-dihydro-1H-indol-1-yl)-3-phenyl-propane-1,2-diol
866210-90-4

(2S,3S)-3-(3,3-dimethyl-2,3-dihydro-1H-indol-1-yl)-3-phenyl-propane-1,2-diol

Conditions
ConditionsYield
at 110℃; for 5h;93%
3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

(2R,3R)-3-(3-fluorophenyl)-2-(hydroxymethyl)oxirane
693220-50-7

(2R,3R)-3-(3-fluorophenyl)-2-(hydroxymethyl)oxirane

(2S,3S)-3-(3,3-dimethyl-2,3-dihydro-1H-indol-1-yl)-3-(3-fluorophenyl)propane-1,2-diol
866210-86-8

(2S,3S)-3-(3,3-dimethyl-2,3-dihydro-1H-indol-1-yl)-3-(3-fluorophenyl)propane-1,2-diol

Conditions
ConditionsYield
at 110℃; for 5h;85%
3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

(2R,3R)-3-(3,5-difluorophenyl)glycidol
866209-32-7

(2R,3R)-3-(3,5-difluorophenyl)glycidol

(2S,3S)-3-(3,5-difluorophenyl)-3-(3,3-dimethyl-2,3-dihydro-1H-indol-1-yl)propane-1,2-diol
866210-88-0

(2S,3S)-3-(3,5-difluorophenyl)-3-(3,3-dimethyl-2,3-dihydro-1H-indol-1-yl)propane-1,2-diol

Conditions
ConditionsYield
at 110℃; for 5h;84%
3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

3,3-dimethyl-indoline; hydrochloride

3,3-dimethyl-indoline; hydrochloride

Conditions
ConditionsYield
With hydrogenchloride In n-heptane; Isopropyl acetate; isopropyl alcohol for 2h;75.5%
3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

ethyl 7-chlorothiazolo[5,4-d]pyrimidine-2-carboxylate

ethyl 7-chlorothiazolo[5,4-d]pyrimidine-2-carboxylate

ethyl 7-(3,3-dimethylindolin-1-yl)thiazolo[5,4-d]pyrimidine-2-carboxylate

ethyl 7-(3,3-dimethylindolin-1-yl)thiazolo[5,4-d]pyrimidine-2-carboxylate

Conditions
ConditionsYield
In isopropyl alcohol at 70℃; for 4h; Sealed tube;74%
3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

2-fluoro-3-nitropyridine
1480-87-1

2-fluoro-3-nitropyridine

3,3-dimethyl-1-(3-nitropyridin-2-yl)indoline
870072-64-3

3,3-dimethyl-1-(3-nitropyridin-2-yl)indoline

Conditions
ConditionsYield
at 200℃; for 0.166667h; microwave;60.4%
In neat (no solvent) at 175℃; Inert atmosphere; Microwave irradiation;
3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

6-[4-(2-oxo-2,3-dihydroimidazo[4,5-b]pyridin-1-yl)-piperidin-1-yl]-pyrimidine-4-carboxylic acid
1159009-67-2

6-[4-(2-oxo-2,3-dihydroimidazo[4,5-b]pyridin-1-yl)-piperidin-1-yl]-pyrimidine-4-carboxylic acid

1-{1-[6-(3,3-dimethyl-2,3-dihydroindole-1-carbonyl)-pyrimidin-4-yl]piperidin-4-yl}-1,3-dihydro-imidazo[4,5-b]pyridin-2-one
1159007-29-0

1-{1-[6-(3,3-dimethyl-2,3-dihydroindole-1-carbonyl)-pyrimidin-4-yl]piperidin-4-yl}-1,3-dihydro-imidazo[4,5-b]pyridin-2-one

Conditions
ConditionsYield
With O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; triethylamine In N,N-dimethyl-formamide at 20℃;57%
2,6-Dichloropyrimidine
3934-20-1

2,6-Dichloropyrimidine

3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

C14H14ClN3

C14H14ClN3

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In tetrahydrofuran at 75℃; for 2.5h;57%
3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

ethyl [4-(morpholin-4-yl)-6-oxo-1,6-dihydropyrimidin-2-yl]acetate
1260543-99-4

ethyl [4-(morpholin-4-yl)-6-oxo-1,6-dihydropyrimidin-2-yl]acetate

2-[2-(3,3-dimethyl-2,3-dihydro-1H-indol-1-yl)-2-oxoethyl]-6-(morpholin-4-yl)pyrimidin-4(3H)-one
1260585-05-4

2-[2-(3,3-dimethyl-2,3-dihydro-1H-indol-1-yl)-2-oxoethyl]-6-(morpholin-4-yl)pyrimidin-4(3H)-one

Conditions
ConditionsYield
Stage #1: ethyl [4-(morpholin-4-yl)-6-oxo-1,6-dihydropyrimidin-2-yl]acetate With sodium hydroxide In tetrahydrofuran at 20℃; for 48h;
Stage #2: 3,3-dimethylindoline With pyridine; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 20℃; for 16h;
54%
3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

sodium salt of (4-methoxy-6-chloropyrimidin-2-yl)acetic acid

sodium salt of (4-methoxy-6-chloropyrimidin-2-yl)acetic acid

2-(4-chloro-6-methoxypyrimidin-2-yl)-1-(3,3-dimethyl-2,3-dihydroindol-1-yl)ethanone
1384070-87-4

2-(4-chloro-6-methoxypyrimidin-2-yl)-1-(3,3-dimethyl-2,3-dihydroindol-1-yl)ethanone

Conditions
ConditionsYield
With pyridine; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 20℃; for 20h;41%
2-furanoic acid
88-14-2

2-furanoic acid

3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

i-propyl isocyanide
598-45-8

i-propyl isocyanide

C19H22N2O3

C19H22N2O3

Conditions
ConditionsYield
With 1-hydroxy-3H-benz[d][1,2]iodoxole-1,3-dione In dimethyl sulfoxide at 20℃; for 48h; Ugi Condensation; diastereoselective reaction;35%
3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

2-butyl-4-chloro-1-((5'-chloro-2'-cyano-[1,1'-biphenyl]-4- yl)methyl)-1H-imidazole-5-carboxylic acid

2-butyl-4-chloro-1-((5'-chloro-2'-cyano-[1,1'-biphenyl]-4- yl)methyl)-1H-imidazole-5-carboxylic acid

trifluoroacetic acid
76-05-1

trifluoroacetic acid

2-butyl-4-chloro-1-((2'-cyano-5'-(3,3-dimethylindolin-l-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-5-carboxylic acid

2-butyl-4-chloro-1-((2'-cyano-5'-(3,3-dimethylindolin-l-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-5-carboxylic acid

Conditions
ConditionsYield
Stage #1: 3,3-dimethylindoline; 2-butyl-4-chloro-1-((5'-chloro-2'-cyano-[1,1'-biphenyl]-4- yl)methyl)-1H-imidazole-5-carboxylic acid With chloro(2-dicyclohexylphosphino-2’,6’-diisopropoxy-1,1’-biphenyl)[2-(2’-amino-1,1‘-biphenyl)]palladium(II) 2nd generation; sodium t-butanolate In tetrahydrofuran at 65℃; for 18h; Inert atmosphere; Sealed tube;
Stage #2: trifluoroacetic acid In water; acetonitrile
29.4%
3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

3,3-dimethyl-2,3-dihydro-1H-indole-6-sulfonic acid
1316066-02-0

3,3-dimethyl-2,3-dihydro-1H-indole-6-sulfonic acid

Conditions
ConditionsYield
With sulfuric acid; sulfur trioxide at 20 - 135℃; for 1.75h;28%
3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

4-(piperidin-1-ylmethyl)benzoyl chloride
768320-30-5

4-(piperidin-1-ylmethyl)benzoyl chloride

(3,3-dimethylindolin-1-yl)(4-(piperidin-1-ylmethyl)phenyl)methanone

(3,3-dimethylindolin-1-yl)(4-(piperidin-1-ylmethyl)phenyl)methanone

Conditions
ConditionsYield
With triethylamine In dichloromethane at 20℃; Schotten-Baumann Reaction; Inert atmosphere;24%
3,3-dimethylindoline
1914-02-9

3,3-dimethylindoline

3-chloro-2-nitropyridine
54231-32-2

3-chloro-2-nitropyridine

3,3-dimethyl-1-(3-nitropyridin-2-yl)indoline
870072-64-3

3,3-dimethyl-1-(3-nitropyridin-2-yl)indoline

Conditions
ConditionsYield
at 220℃; for 0.25h; Microwave irradiation;18%

1914-02-9Relevant articles and documents

Experimental and Computational Studies of High-Valent Nickel and Palladium Complexes

Camasso, Nicole M.,Canty, Allan J.,Ariafard, Alireza,Sanford, Melanie S.

, p. 4382 - 4393 (2017)

This article describes a detailed comparison of the organometallic chemistry of high-valent nickel and palladium model complexes supported by tris(pyrazolyl)borate and cycloneophyl ligands. The accessibility of the MIII and MIV oxidation states with each metal is investigated through electrochemical and chemical oxidation of the MII precursors. These studies show that the NiII precursor readily undergoes both one- and two-electron oxidations to generate stable NiIII and NiIV products. In contrast, under the conditions examined, the PdII analogue undergoes exclusively two-electron-oxidation reactions to form PdIV. Reactivity studies of isolated NiIV and PdIV complexes show that both participate in C(sp3)-heteroatom coupling reactions and that the reactions at NiIV are approximately 2 orders of magnitude faster than those at PdIV. Experimental and computational mechanistic studies implicate outer-sphere SN2-type pathways for these processes. With most nucleophiles (e.g., phenoxide, acetate, thiophenoxide), the C(sp3)-heteroatom coupling reaction yields a TpMII(σ-aryl) product. However, with azide as the nucleophile, the NiII product of initial C(sp3)-N3 coupling undergoes a subsequent C(sp2)-N insertion reaction. Computations implicate an anionic NiIII-nitrene intermediate in this process and show that the Pd analogue of this species is a much higher energy species. Overall, the combined experimental and computational studies demonstrate remarkable similarities in the chemistry of NiIV and PdIV but an enhanced role for NiIII in enabling reactivity which is distinct from that of palladium.

4 - Substituted benzene sulfonamide derivative and its preparation method and application

-

Paragraph 0153-0156, (2018/04/21)

The present invention discloses a class of new 4-substituted benzene sulfonamide derivatives represented by a formula (I), wherein the 4-substituted benzene sulfonamide derivatives have good antitumor activity, and each group is defined in the specification. The present invention further discloses a preparation method of the derivative, a pharmaceutical composition containing the derivative, and applications of the 4-substituted benzene sulfonamide derivative and the pharmaceutical composition containing the derivative as the antitumor drug. The formula I is defined in the specification.

Substituted ring compound and its method and use thereof

-

Paragraph 0474; 0475; 0476; 0477, (2017/08/25)

The invention provides a substituted cyclic compound as well as a use method and application thereof. The compound is a compound as shown in a formula (I) or stereoisomers, stereomers, tautomers, nitric oxides, solvates, metabolites and pharmaceutically acceptable salts or prodrugs of the compound as shown in the formula (I). The invention further provides a medicament composition containing the compound. The compound and the medicament composition are capable of regulating the activity of protein kinase in a biological sample body and are used for protecting, treating or relieving proliferative diseases of patients. The formula (I) is as shown in the specification.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1914-02-9